Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients. 1983

B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally

Two analogs of somatostatin (Ala2,D-Trp8,D-Cys14-Somatostatin and L-5F-Trp8-Somatostatin) infused into acromegalics at the rate of 4.5 micrograms/min suppressed arginine-stimulated growth hormone release more strongly than 6 micrograms/min somatostatin (110 +/- 11% and 129 +/- 14%, respectively). Under the same conditions the two somatostatin analogs induced a much smaller inhibition of insulin (33 +/- 13% and 44 +/- 18%) and glucagon (28 +/- 10% and 45 +/- 17%, respectively) release than somatostatin did. Somatostatin analogs with dissociated actions could be promising for the treatment of diseases such as acromegaly, diabetes mellitus and some ectopic hormone syndromes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000172 Acromegaly A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80) Inappropriate Growth Hormone Secretion Syndrome (Acromegaly),Somatotropin Hypersecretion Syndrome (Acromegaly),Inappropriate GH Secretion Syndrome (Acromegaly),Hypersecretion Syndrome, Somatotropin (Acromegaly),Hypersecretion Syndromes, Somatotropin (Acromegaly),Somatotropin Hypersecretion Syndromes (Acromegaly),Syndrome, Somatotropin Hypersecretion (Acromegaly),Syndromes, Somatotropin Hypersecretion (Acromegaly)
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate

Related Publications

B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
August 1987, Life sciences,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
January 1977, Biochemical and biophysical research communications,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
April 1974, Lancet (London, England),
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
February 1976, Endocrinology,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
October 1975, FEBS letters,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
December 1977, Acta endocrinologica,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
August 2000, The Journal of clinical endocrinology and metabolism,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
January 1980, Journal of endocrinological investigation,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
September 1978, Metabolism: clinical and experimental,
B L Wajchenberg, and F P Cesar, and C E Leme, and V C Borghi, and V C Souza, and I T Souza, and D G Neto, and O A Germek, and D H Coy, and A M Comaru-Schally
April 1976, Acta endocrinologica,
Copied contents to your clipboard!